Amazon
AMZN
Meta Platforms
META
Tesla
TSLA
4
Apple
AAPL
5
Salesforce
CRM
US Stock MarketDetailed Quotes
KALV KalVista Pharmaceuticals
- 12.180
- +0.280+2.35%
Close May 12 16:00 ET
- 12.150
- -0.030-0.25%
Post 20:01 ET
605.54MMarket Cap-3.23P/E (TTM)
12.520High11.990Low543.24KVolume12.000Open11.900Pre Close6.67MTurnover1.87%Turnover RatioLossP/E (Static)49.72MShares15.50052wk High4.17P/B354.10MFloat Cap7.30052wk Low--Dividend TTM29.07MShs Float129.108Historical High--Div YieldTTM4.45%Amplitude4.120Historical Low12.271Avg Price1Lot Size
KalVista Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.53%-32.68M | -99.96%-39.64M | -50.47%-40.22M | -18.56%-89.23M | 33.27%-15.11M | -196.81%-27.57M | 3.73%-19.83M | -17.54%-26.73M | 3.68%-75.26M | 15.50%-22.64M |
| Net income from continuing operations | -67.11%-48.51M | -52.86%-42.27M | -59.75%-40.44M | -36.31%-126.64M | -69.74%-44.65M | -36.26%-29.03M | -24.23%-27.65M | -9.87%-25.32M | -12.83%-92.91M | -9.09%-26.31M |
| Operating gains losses | 1,127.06%4.48M | -226.68%-774K | -3.10%-731K | 61.80%-565K | 86.16%-31K | 27.45%-436K | 155.75%611K | -260.41%-709K | -169.34%-1.48M | -119.67%-224K |
| Depreciation and amortization | 10.63%229K | 15.23%227K | 16.06%224K | 13.65%816K | 16.49%219K | 4.02%207K | 13.87%197K | 22.15%193K | 27.30%718K | 20.51%188K |
| Other non cash items | 145,700.00%2.92M | -136.84%-45K | -183.33%-5K | -114.29%-12K | -103.13%-1K | -80.00%2K | -200.00%-19K | -73.91%6K | -53.07%84K | 23.08%32K |
| Change In working capital | 641.96%5.59M | -94.41%213K | 45.25%-2.31M | 104.60%15.17M | 1,364.73%16.61M | -110.47%-1.03M | 1,784.96%3.81M | -25.72%-4.22M | 160.16%7.41M | 115.89%1.13M |
| -Change in receivables | 250.00%3.16M | 47.26%-1.07M | 39.88%-1.25M | 453.02%8.18M | 429.69%14.39M | -122.93%-2.11M | 43.23%-2.03M | 41.62%-2.08M | 55.47%-2.32M | -17.21%-4.37M |
| -Change in prepaid assets | -1,064.14%-1.4M | 19.27%2.1M | 21.93%-783K | -108.04%-538K | -164.18%-1.44M | -81.65%145K | 2.86%1.76M | -151.83%-1M | 172.09%6.69M | 140.03%2.25M |
| -Change in payables and accrued expense | 312.49%3.83M | -120.23%-823K | 75.80%-274K | 147.75%7.53M | 12.74%3.66M | 907.83%929K | 150.25%4.07M | 34.22%-1.13M | 40.76%3.04M | 47.01%3.25M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.53%-32.68M | -99.96%-39.64M | -50.47%-40.22M | -18.56%-89.23M | 33.27%-15.11M | -196.81%-27.57M | 3.73%-19.83M | -17.54%-26.73M | 3.68%-75.26M | 15.50%-22.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 227.08%8.52M | 70.45%48.67M | 89.48%37.16M | -304.56%-84.72M | -1,931.98%-126.19M | -166.27%-6.7M | 42.08%28.56M | -34.72%19.61M | -28.42%41.42M | -149.94%-6.21M |
| Capital expenditure reported | -13.19%-103K | 53.69%-94K | ---64K | ---401K | ---107K | ---91K | ---203K | --0 | --0 | ---- |
| Net PPE purchase and sale | -26.32%-24K | -5,300.00%-108K | -250.00%-21K | 96.49%-42K | 78.26%-15K | -26.67%-19K | 98.96%-2K | 99.35%-6K | -28.46%-1.2M | 19.77%-69K |
| Net investment purchase and sale | 231.13%8.64M | 69.93%48.88M | 89.85%37.25M | -297.78%-84.28M | -1,952.83%-126.06M | -163.47%-6.59M | 41.75%28.76M | -36.64%19.62M | -27.52%42.61M | -149.05%-6.14M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 227.08%8.52M | 70.45%48.67M | 89.48%37.16M | -304.56%-84.72M | -1,931.98%-126.19M | -166.27%-6.7M | 42.08%28.56M | -34.72%19.61M | -28.42%41.42M | -149.94%-6.21M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 53,341.20%151.77M | 130.47%295K | 1,370.59%3M | 159.33%150.71M | 454,942.42%150.1M | -99.51%284K | -23.81%128K | 21.43%204K | 3,575.90%58.12M | -123.91%-33K |
| Net common stock issuance | ---- | ---- | ---- | 71.34%96.95M | --96.95M | ---- | ---- | ---- | --56.58M | --0 |
| Proceeds from stock option exercised by employees | 122.54%632K | 130.47%295K | 1,370.59%3M | 3,405.15%53.77M | 161,169.70%53.15M | -76.93%284K | -23.81%128K | 21.43%204K | -2.97%1.53M | -123.91%-33K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 53,341.20%151.77M | 130.47%295K | 1,370.59%3M | 159.33%150.71M | 454,942.42%150.1M | -99.51%284K | -23.81%128K | 21.43%204K | 3,575.90%58.12M | -123.91%-33K |
| Net cash flow | ||||||||||
| Beginning cash position | -27.89%41.58M | -35.54%31.85M | -43.47%31.79M | 82.99%56.24M | -72.89%23.06M | 49.45%57.67M | 30.49%49.41M | 82.99%56.24M | -39.26%30.73M | 86.61%85.05M |
| Current changes in cash | 475.44%127.61M | 5.27%9.33M | 99.16%-58K | -195.74%-23.24M | 130.50%8.81M | -173.88%-33.99M | 2,800.91%8.86M | -192.54%-6.91M | 229.83%24.27M | -103.13%-28.88M |
| Effect of exchange rate changes | -101.13%-1.25M | 167.61%407K | 39.29%117K | -198.14%-1.21M | -208.82%-74K | -235.89%-621K | -157.33%-602K | 124.78%84K | 205.91%1.24M | 110.83%68K |
| End cash Position | 628.40%167.94M | -27.89%41.58M | -35.54%31.85M | -43.47%31.79M | -43.47%31.79M | -72.89%23.06M | 49.45%57.67M | 30.49%49.41M | 82.99%56.24M | 82.99%56.24M |
| Free cash flow | -18.52%-32.81M | -98.92%-39.84M | -50.75%-40.31M | -17.29%-89.67M | 32.94%-15.23M | -197.52%-27.68M | 3.64%-20.03M | -12.99%-26.74M | 3.30%-76.46M | 15.52%-22.71M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025